Pharmaceuticals

Maize and blue graphic of a vaccine.

Exploring the cost-effectiveness of RSV vaccines in older adults

Q&A with David Hutton

David Hutton, a professor of Health Management and Policy and Global Public Health, discusses the cost-effectiveness of RSV vaccination in older adults. Hutton and a group of University of Michigan researchers recently presented research on the topic during a meeting for the CDC's Advisory Committee on Immunization Practices (ACIP).